46 related articles for article (PubMed ID: 2274634)
1. Treatment of supersensitivity psychosis with antiepileptic drugs: report of a series of 43 cases.
Chouinard G; Sultan S
Psychopharmacol Bull; 1990; 26(3):337-41. PubMed ID: 2274634
[TBL] [Abstract][Full Text] [Related]
2. Antiepileptic drugs in the treatment of neuroleptic-induced supersensitivity psychosis.
Sultan S; Chouinard G; Beaudry P
Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(3):431-8. PubMed ID: 1972802
[TBL] [Abstract][Full Text] [Related]
3. Neuroleptic-induced supersensitivity psychosis: retrospective study of schizophrenic inpatients.
Hunt JI; Singh H; Simpson GM
J Clin Psychiatry; 1988 Jul; 49(7):258-61. PubMed ID: 2899071
[TBL] [Abstract][Full Text] [Related]
4. Effects of verapamil on tardive dyskinesia and psychosis in schizophrenic patients.
Reiter S; Adler L; Angrist B; Peselow E; Rotrosen J
J Clin Psychiatry; 1989 Jan; 50(1):26-7. PubMed ID: 2562952
[TBL] [Abstract][Full Text] [Related]
5. Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis.
Small JG; Milstein V; Marhenke JD; Hall DD; Kellams JJ
J Clin Psychiatry; 1987 Jul; 48(7):263-7. PubMed ID: 2885310
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics.
Chouinard G; Jones BD
Am J Psychiatry; 1980 Jan; 137(1):16-21. PubMed ID: 6101522
[TBL] [Abstract][Full Text] [Related]
7. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):761-4. PubMed ID: 18201810
[TBL] [Abstract][Full Text] [Related]
8. Clozapine maintenance therapy in schizophrenia.
Gaszner P; Makkos Z
Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
[TBL] [Abstract][Full Text] [Related]
9. [Lack of involuntary abnormal movements in untreated schizophrenic patients].
Hernán Silva I; Jerez CS; Ruiz TA; Seguel LM; Court LJ; Labarca BR
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1994; 22(5):200-2. PubMed ID: 7817846
[TBL] [Abstract][Full Text] [Related]
10. [Social integration of long-term paraphrenic patients with low-dose depot neuroleptic medication].
Lesch OM; Dietzel-Rogan M; Musalek M; Rajna P; Rustembegovich A; Schjerve M; Walter H
Psychiatr Prax; 1985 Mar; 12(2):63-8. PubMed ID: 3887443
[TBL] [Abstract][Full Text] [Related]
11. Do anticonvulsants hinder clozapine treatment?
Wilson WH
Biol Psychiatry; 1995 Jan; 37(2):132-3. PubMed ID: 7718678
[No Abstract] [Full Text] [Related]
12. [Adverse effects of long-term psychopharmacologic therapy on sexual functions].
Pfeiffer W; Kockott G; Fischl B; Schleuning G
Psychiatr Prax; 1991 May; 18(3):92-8. PubMed ID: 1886955
[TBL] [Abstract][Full Text] [Related]
13. Early phase II clinical trial of remoxipride in treatment of schizophrenia with measurements of prolactin and neuroleptic activity.
Chouinard G
J Clin Psychopharmacol; 1987 Jun; 7(3):159-64. PubMed ID: 2885345
[TBL] [Abstract][Full Text] [Related]
14. Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale.
Harvey PD; Davidson M; White L; Keefe RS; Hirschowitz J; Mohs RC; Davis KL
Biol Psychiatry; 1996 Oct; 40(8):755-60. PubMed ID: 8894068
[TBL] [Abstract][Full Text] [Related]
15. A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation.
Chouinard G; Safadi G; Beauclair L
J Clin Psychopharmacol; 1994 Dec; 14(6):377-84. PubMed ID: 7884017
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy and tolerability of quetiapine in hospitalised schizophrenic patients during the acute treatment phase: a PMS study].
Leweke FM; Gerth CW; Koethe D; Nolden BM; Klosterkötter J
Fortschr Neurol Psychiatr; 2007 Apr; 75(4):211-9. PubMed ID: 17230308
[TBL] [Abstract][Full Text] [Related]
17. [Modification of long-term schizophrenia by somato-therapeutic measures].
Gross G; Huber G; Schüttler R
Psychiatr Clin (Basel); 1980; 13(3-4):179-92. PubMed ID: 6113621
[TBL] [Abstract][Full Text] [Related]
18. Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases.
Friedman JH
Mov Disord; 1994 May; 9(3):321-4. PubMed ID: 7913739
[TBL] [Abstract][Full Text] [Related]
19. [Treatment refractory schizophrenia].
Vanelle JM
Encephale; 1995 Jun; 21 Spec No 3():13-21. PubMed ID: 7628336
[TBL] [Abstract][Full Text] [Related]
20. Subjective side effects of antipsychotics and medication adherence in people with schizophrenia.
McCann TV; Clark E; Lu S
J Adv Nurs; 2009 Mar; 65(3):534-43. PubMed ID: 19222651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
